Scientists have created a new zebrafish xenograft platform to screen for novel treatments for an aggressive brain tumor called glioblastoma, according to a new study published in EMBO Molecular Medicine.
Oct 4, 2023
0
30
By genetically testing nearly 1,000 embryos, scientists have provided the most detailed analysis of embryo fate following human in vitro fertilization.
Oct 1, 2023
0
50
Becoming a full-fledged organism out of a handful of cells, complete with functioning tissues and organs, is a messy yet highly synchronized process that requires cells to organize themselves in a precise manner and begin ...
Sep 27, 2023
0
52
Scientists have developed human embryo-like structures without using sperm, an egg or fertilization, offering hope for research on miscarriage and birth defects but also raising fresh ethical concerns.
Sep 7, 2023
0
37
Stem cells are special kinds of cells in our body that can become any other type of cell. They have huge potential for medicine, and trials are currently under way using stem cells to replace damaged cells in diseases like ...
Aug 20, 2023
0
65
Scientists have relied on animal models as an alternative to testing on human tissues and cells for decades. But not just any organism can adequately model how human cells behave. Researchers take into account how quickly ...
Aug 8, 2023
0
1
Scientists hope to learn more about the earliest stages of human development using models of embryos created from stem cells.
Jul 3, 2023
0
12
Nausea, neurologic pain and hair loss are some of the severe side effects of chemotherapy. But they are not a necessary hardship, says biochemist Liyan Zhang. Together with Leiden biologists and others, she achieved promising ...
Jun 29, 2023
0
1
A preclinical study using stem cells to produce progenitor photoreceptor cells—light-detecting cells found in the eye—and then transplanting these into experimental models of damaged retinas has resulted in significant ...
Apr 14, 2023
0
81
For the first time, scientists have created baby mice from two males.
Mar 15, 2023
0
3
